HI
NUVL

HBK Investments’s Nuvalent NUVL Stock Holding History

HBK Investments’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430M Buy
+3,483,100
New +$375M 4.2% 8

Other funds holding NUVL

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

HBK Investments's NUVL Position: Q2 2026 in Review

HBK Investments opened a new position in Nuvalent (NUVL) in Q2 2026: 3,483,100 shares worth $430M. The stake represents 4.2% of the portfolio and ranks #8 among its holdings.

261 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • HBK Investments held 3,483,100 shares of Nuvalent worth $430M as of Q2 2026.
  • Nuvalent was a new HBK Investments position in Q2 2026.
  • Nuvalent made up 4.2% of HBK Investments's portfolio in Q2 2026, its #8 holding.
  • 261 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on HBK Investments's 13F filing for Q2 2026, filed 14 Aug 2026.